ResearcherCentral South UniversityActive in the last 2 years

Yebin Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-9991-1033; OpenAlex author ID A5004766575. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

METTL3-driven m6A modification promotes tumor progression and immune evasion in hypoxic pancreatic cancer by enhancing ADAM10-mediated MICA shedding. Last author DOI 10.1186/s12967-026-08238-3 ↗
Identification of significant prognostic risk markers for pancreatic ductal adenocarcinoma: a bioinformatic analysis. Last author DOI 10.18388/abp.2020_5758 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xuejun Gong · 1 shared paper, 2026 · strength 0.36
- Paper METTL3-driven m6A modification promotes tumor progression and immune evasion in hypoxic pancreatic cancer by enhancing … DOI 10.1186/s12967-026-08238-3 ↗
Fan Zhang · 1 shared paper, 2026 · strength 0.36
- Paper METTL3-driven m6A modification promotes tumor progression and immune evasion in hypoxic pancreatic cancer by enhancing … DOI 10.1186/s12967-026-08238-3 ↗
Zhipeng Zhang · 1 shared paper, 2022 · strength 0.22
- Paper Identification of significant prognostic risk markers for pancreatic ductal adenocarcinoma: a bioinformatic analysis. DOI 10.18388/abp.2020_5758 ↗
Weijia Sun · 1 shared paper, 2022 · strength 0.22
- Paper Identification of significant prognostic risk markers for pancreatic ductal adenocarcinoma: a bioinformatic analysis. DOI 10.18388/abp.2020_5758 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.